Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Aldesleukin
(Interleukin-2)		[1] Aldesleukin (Recombinant interleukin-2 human)[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[5] 2, 49, 65, 96, 97 💬
2ANTI-human interleukin-23 monoclonal antibody----[1] 271 💬
3ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody----[2] 96, 97 💬
4Interleukin-2[1] Human interleukin-2 (INTERLEUKIN-2)---[9] 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
5LOW-dose interleukin-2----[1] 53 💬
6Monthly autologous treg cells infusions + 3 times PER week interleukin-2 injections----[1] 2 💬
7PEG-interleukin-2[1] PEG-interleukin-2 (Polyethylene glycol-modified recombinant interleukin-2)---[1] 65 💬
8Recombinant human interleukin-2[1] Aldesleukin (Recombinant interleukin-2 human)[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35 💬